Novatio Ventures
Novatio Ventures accelerates the commercialization of high-potential, high-impact life science innovations. Based in Toronto, Boston, and Hong Kong, it focuses on early-stage innovations from various markets, providing seed funding and active support to inventors, entrepreneurs, and institutions to develop and commercialize their technologies. The company aims for early exits with attractive, risk-mitigated financial returns, leveraging its global experience and network.
Industries
Novatio Ventures
Toronto, Ontario, Canada, North America
Services
Seed investment and fundraising advisory
Provide direct seed funding and advise on optimal fundraising strategies for early-stage life science innovations.
Company structuring and interim management
Advise on entity structure and provide interim executive and operational management to establish development plans and accelerate progress to milestones.
Licensing, partnerships and monetization services
Originate and execute licensing and partnership deals, perform partner screening, and lead deal structuring, valuation and negotiations to monetize technologies.
Seed investment and fundraising advisory
Provide direct seed funding and advise on optimal fundraising strategies for early-stage life science innovations.
Company structuring and interim management
Advise on entity structure and provide interim executive and operational management to establish development plans and accelerate progress to milestones.
Licensing, partnerships and monetization services
Originate and execute licensing and partnership deals, perform partner screening, and lead deal structuring, valuation and negotiations to monetize technologies.
Expertise Areas
- Preclinical development and translation
- Biomarker discovery and management
- Molecular diagnostics and proteomics
- Immunotherapy translational research
Key Technologies
- Genomics
- Biomarker discovery
- Molecular diagnostic assays
- Proteomics